Indication:Overactive bladder syndrome
NICE TA 290
Mirabegron is recommended as an option for treating the symptoms of overactive bladder only for people in whom antimuscarinic drugs are contraindicated or clinically ineffective, or have unacceptable side effects.
People currently receiving mirabegron that is not recommended for them should be able to continue treatment until they and their clinician consider it appropriate to stop.
Further info at
Issued: June 2013